Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ATAI Life Sciences NV (ATAI)

ATAI Life Sciences NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATAI
DateTimeSourceHeadlineSymbolCompany
31/05/202412:00GlobeNewswire Inc.atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare ConferenceNASDAQ:ATAIATAI Life Sciences NV
23/05/202412:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
23/05/202412:00GlobeNewswire Inc.atai Life Sciences Strengthens Board with Appointment of Two New Independent DirectorsNASDAQ:ATAIATAI Life Sciences NV
20/05/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
15/05/202412:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATAIATAI Life Sciences NV
15/05/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
15/05/202411:59GlobeNewswire Inc.atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:ATAIATAI Life Sciences NV
24/04/202412:00GlobeNewswire Inc.atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
17/04/202412:00GlobeNewswire Inc.atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of PsychopharmacologyNASDAQ:ATAIATAI Life Sciences NV
28/03/202411:00GlobeNewswire Inc.atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical HighlightsNASDAQ:ATAIATAI Life Sciences NV
27/03/202411:00GlobeNewswire Inc.atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV
04/03/202413:00GlobeNewswire Inc.atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01NASDAQ:ATAIATAI Life Sciences NV
28/02/202422:00GlobeNewswire Inc.atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care ConferenceNASDAQ:ATAIATAI Life Sciences NV
13/02/202421:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATAIATAI Life Sciences NV
06/02/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
06/02/202422:00GlobeNewswire Inc.atai Life Sciences Appoints Anne Johnson as Chief Financial OfficerNASDAQ:ATAIATAI Life Sciences NV
23/01/202412:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
09/01/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
09/01/202421:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
04/01/202413:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
04/01/202412:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
04/01/202412:00GlobeNewswire Inc.atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration PsychedelicsNASDAQ:ATAIATAI Life Sciences NV
02/01/202413:00GlobeNewswire Inc.atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)NASDAQ:ATAIATAI Life Sciences NV
20/11/202314:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATAIATAI Life Sciences NV
14/11/202312:03GlobeNewswire Inc.atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline HighlightsNASDAQ:ATAIATAI Life Sciences NV
13/10/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
10/10/202313:00PR Newswire (Canada)ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORTNASDAQ:ATAIATAI Life Sciences NV
06/10/202321:05GlobeNewswire Inc.atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro SummitNASDAQ:ATAIATAI Life Sciences NV
02/10/202321:13GlobeNewswire Inc.atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy ParticipantsNASDAQ:ATAIATAI Life Sciences NV
29/09/202321:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATAIATAI Life Sciences NV
 Showing the most relevant articles for your search:NASDAQ:ATAI